P/E của cổ phiếu JNJ là bao nhiêu?

JOHNSON & JOHNSON (JNJ) hiện giao dịch ở mức P/E 29.31 lần.

ROE của cổ phiếu JNJ là bao nhiêu?

JOHNSON & JOHNSON có tỷ suất lợi nhuận trên vốn chủ sở hữu (ROE) 24.76%.

Tỷ suất cổ tức của JNJ là bao nhiêu?

JOHNSON & JOHNSON có tỷ suất cổ tức 1.97%.

Điểm chất lượng (Quality Score) của JNJ là bao nhiêu?

AI của chúng tôi đánh giá chất lượng tài chính tổng thể của JNJ ở mức 85/100, dựa trên khả năng sinh lời, tăng trưởng, nợ và độ ổn định lợi nhuận.

Bây giờ có nên mua cổ phiếu JNJ không?

Điểm AI Timing của JNJ là 89/100, thể hiện mức độ hấp dẫn tương đối của giá hiện tại theo tín hiệu kỹ thuật và momentum — nên cân nhắc cùng điểm chất lượng và kế hoạch đầu tư của bạn.

Cổ phiếu JNJ thuộc ngành nào?

JOHNSON & JOHNSON được xếp vào ngành Healthcare >> Drug Manufacturers - General trên sàn NYSE

Cổ phiếu JNJ (NYSE) | JOHNSON & JOHNSON

Stock Check Daily update data at 8:30 AM
(Price: 2026-07-31 | FS: 2026-06-30)

JNJ AI Analysis Summary

Our AI summary for JNJ: JOHNSON & JOHNSON (NYSE), Healthcare >> Drug Manufacturers - General sector. The stock currently trades at a P/E of 29.31, ROE of 24.76%, a dividend yield of 1.97%. Its financial Quality Score stands at 85/100 — fundamentals stronger than most of the market. The AI Timing Score is 89/100 — multiple technical signals currently support price momentum. All scores are recomputed automatically after each market close from official exchange data. This is systematically generated analysis, not personalized investment advice.

JNJ

JOHNSON & JOHNSON

USD 256.35

0.53 (0.21%) Day Change

Watchlist Portfolio Compare Chart

29.31

P/E

0.58

D/E

24.8%

ROE

10.5%

ROA

1.97%

Div Yield

JOHNSON & JOHNSON
TYPE: STOCK
MARKET: NYSE

Compare Watchlist Myport

USD 256.35 Price 0.53 (0.21%) Day Change	NEWS SCORE: 99

JNJ Chất lượng tổng thể của cố phiếu Rất tốt ( Chất lượng = 85) và Thời điểm mua ...(Sign In to See)...

Loading chart...

85 QUALITY

Signal: OUTPERFORM

Signal Description: Company financial health is Good

Reason: ROE đang giảm đáng kể
ROA quá thấp so với ROE

88 Sign in

TIMING

Signal: OUTPERFORM

Signal Descri...: Good

Reason: Momentum indicators aligned on the daily timeframe

Unlock timing signals and detailed reasons

Chi tiết hơn, sẽ thấy rằng các yếu tố chất lượng Không tốt lắm , Sức khỏe tài chính Không tốt lắm , và khả năng kiếm lợi nhuận Tốt , ...

Yếu tố Chất lượng

54%

In Recommendations?	Not in any sections
Select Rate	0.00 From 30 days period
Watch Rate	0.00 From 30 days period
News Score	99
Magic Formula Rank by ROA	1050
Magic Formula Rank by ROE	1050
Magic Formula Rank by ROIC	1342
Price	256.35
PBV / Sector	7.26 / 2.68
Earning Per Share	8.75

PE / Sector	29.31 / 27.65
PEG or PE/Growth / Sector	N/A / 0.28
Average 1M Daily Value	1,761.97 M GREAT
Average 1W Daily Value	1,751.55 M GREAT

Yếu tố Kỹ thuật

57%

MACD	SIGN IN
MACD Signal	SIGN IN
MACD Divergence	SIGN IN
RSI	SIGN IN
Stochastic Oscillator K	SIGN IN
Stochastic Oscillator D	SIGN IN
ADX	SIGN IN
Avg 5 day Timing Score	SIGN IN

Sức khỏe tài chính

58%

DE / Sector	SIGN IN
DE Average / Sector	SIGN IN
DE Change Average (%) / Sector	SIGN IN
Current Ratio / Sector	SIGN IN
Current Ratio Average / Sector	SIGN IN
Current Ratio Change Average (%) / Sector	SIGN IN
Quick Ratio / Sector	SIGN IN
Quick Ratio Average / Sector	SIGN IN
Quick Ratio Change Average (%) / Sector	SIGN IN
FCF/Share / Sector	SIGN IN
FCF/Share Average / Sector	SIGN IN
FCF/Share Change Average (%) / Sector	SIGN IN

Khả năng kiếm lợi nhuận

75%

GPM (%) / Sector	SIGN IN
GPM Average (%) / Sector	SIGN IN
GPM Change Average (%) / Sector	SIGN IN
OPM (%) / Sector	SIGN IN
OPM Average (%) / Sector	SIGN IN
OPM Change Average (%) / Sector	SIGN IN
NPM (%) / Sector	21.48 / 17.30 GREAT
NPM Average (%) / Sector	25.90 / 17.60 GREAT
NPM Change Average (%) / Sector	19.40 / 92.67 GOOD
Asset Turnover / Sector	SIGN IN
Asset Turnover Average / Sector	SIGN IN
Asset Turnover Change Average (%) / Sector	SIGN IN
ROA (%) / Sector	10.46 / 8.73
ROA Average (%) / Sector	12.46 / 8.56
ROA Change Average (%) / Sector	26.60 / 94.23 GREAT
ROE (%) / Sector	24.76 / 26.78 GOOD
ROE Average (%) / Sector	30.36 / 13.05 GREAT
ROE Change Average (%) / Sector	24.92 / 96.64 GREAT
ROIC (%) / Sector	SIGN IN
ROIC Average (%) / Sector	SIGN IN
ROIC Change Average (%) / Sector	SIGN IN

Lợi tức cho nhà đầu tư

12%

Dividend (%) / Sector	1.97 / 2.40
Dividend Average (%) / Sector	2.79 / 3.39
Dividend Change Average (%) / Sector	-6.21 / 4.92

Chi tiết đăng ký

Analyze Date	2026-08-01 08:00:04
Symbol	JNJ
Name	JOHNSON & JOHNSON
Sector	Healthcare >> Drug Manufacturers - General
Market	NYSE
Listed Shares	2,409.90 M
Par Value	N/A
Calculated From	Quarter
Sign	N/A
Market Cap (M.USD) / Sector Average	616,500.23 / 256,404.20

Tin tức, Dự báo ước tính

Estimation Consensus	See at WSJ.com
Full details	See at WSJ.com
Chart	See in Chart feature
News	See at Yahoo Finance

Address: One Johnson & Johnson Plaza, New Brunswick, NJ, United States, 08933

Phone: 732 524 0400

Website: https://www.jnj.com

Employees: 138,200

Sector: Healthcare >> Drug Manufacturers - General

Description: Johnson & Johnson, together with its subsidiaries, engages in the research and development, manufacture, and sale of a range of products in the healthcare field worldwide. It operates in two segments, Innovative Medicine and MedTech. The Innovative Medicine segment offers products for various therapeutic areas, such as oncology, immunology, neuroscience, pulmonary hypertension, infectious diseases, and cardiovascular and metabolism distributed through retailers, wholesalers, distributors, hospitals, and healthcare professionals for prescription use. The MedTech segment provides a portfolio of products used in the surgery, orthopedic, cardiovascular, and vision fields distributed through wholesalers, hospitals and retailers, and used in the professional fields by physicians, nurses, hospitals, eye care professionals and clinics. This segment also offers products and enabling technologies that support joint reconstruction, trauma, spine, sports related injuries, and others, as well as open, laparoscopic, and robotic surgical procedures; instrumentation, energy devices, stapling systems, wound closure, biosurgery products, and digital and robotic technologies; breast aesthetics and reconstruction; contact lenses under the ACUVUE brand; intraocular lenses for cataract surgery, and other products used in cataract and refractive procedures under the TECNIS brand. The company was founded in 1886 and is based in New Brunswick, New Jersey.